Skip to content
10-Q

Quarterly Report

THC THERAPEUTICS, INC.

0001477932-22-009498

← back to feed
Filed
Dec 22, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Dec 9, 2022 34.15M sh
Cash And Equivalents Q1 2023 · Oct 31, 2022 $3.56K
Cash And Equivalents Q1 2023 · Jul 31, 2022 $32
Current Liabilities Q1 2023 · Oct 31, 2022 $5.18M
Current Liabilities Q1 2023 · Jul 31, 2022 $3.22M
Total Liabilities Q1 2023 · Oct 31, 2022 $5.18M
Total Liabilities Q1 2023 · Jul 31, 2022 $3.22M
Current Assets Q1 2023 · Oct 31, 2022 $43.56K
Current Assets Q1 2023 · Jul 31, 2022 $40.71K
Total Assets Q1 2023 · Oct 31, 2022 $56.61K
Total Assets Q1 2023 · Jul 31, 2022 $206.9K
Eps Basic Q1 2023 · Oct 31, 2022 −$0.06
Eps Basic Q1 2023 · Oct 31, 2021 −$0.02
Sga Expense Q1 2023 · Oct 31, 2022 $7.79K
Sga Expense Q1 2023 · Oct 31, 2021 $62.46K
Operating Cash Flow Q1 2023 · Oct 31, 2021 −$158.68K
Stockholders Equity Q1 2023 · Oct 31, 2021 −$2.93M
Stockholders Equity Q1 2023 · Jul 31, 2021 −$2.48M
Net Income Q1 2023 · Oct 31, 2021 −$486.44K
Operating Income Q1 2023 · Oct 31, 2021 −$221.56K
Gross Profit Q1 2023 · Oct 31, 2021 $0
Cost Of Revenue Q1 2023 · Oct 31, 2021 $0
Revenue Q1 2023 · Oct 31, 2021 $0